Amundi Grows Stake in Avantor, Inc. (NYSE:AVTR)

Amundi grew its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 3.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,752,769 shares of the company's stock after buying an additional 64,781 shares during the period. Amundi owned 0.26% of Avantor worth $38,789,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its holdings in Avantor by 99.5% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company's stock worth $26,000 after purchasing an additional 625 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company's stock worth $34,000 after purchasing an additional 830 shares in the last quarter. Global Retirement Partners LLC lifted its holdings in Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company's stock worth $52,000 after purchasing an additional 1,067 shares in the last quarter. UMB Bank n.a. lifted its holdings in Avantor by 56.3% during the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company's stock worth $63,000 after purchasing an additional 1,074 shares in the last quarter. Finally, CKW Financial Group lifted its holdings in Avantor by 116.7% during the 4th quarter. CKW Financial Group now owns 5,200 shares of the company's stock worth $110,000 after purchasing an additional 2,800 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on AVTR shares. Raymond James restated an "outperform" rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Stifel Nicolaus decreased their target price on Avantor from $28.00 to $26.00 and set a "buy" rating on the stock in a research note on Monday, February 10th. Wells Fargo & Company decreased their target price on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Morgan Stanley decreased their target price on Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Monday, February 10th. Finally, UBS Group restated a "neutral" rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat, Avantor presently has a consensus rating of "Moderate Buy" and a consensus target price of $25.50.

Insider Activity at Avantor

In related news, EVP James Bramwell sold 3,758 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now directly owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Steven W. Eck sold 4,907 shares of the stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now owns 40,604 shares of the company's stock, valued at $711,788.12. This represents a 10.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by company insiders.

Avantor Price Performance

Shares of Avantor stock traded up $0.52 during trading on Friday, hitting $16.34. 5,096,664 shares of the stock traded hands, compared to its average volume of 6,242,846. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The stock has a market cap of $11.12 billion, a price-to-earnings ratio of 15.71, a PEG ratio of 1.55 and a beta of 1.30. The firm's fifty day moving average is $19.51 and its 200-day moving average is $22.03. Avantor, Inc. has a 52 week low of $15.37 and a 52 week high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter last year, the firm posted $0.22 EPS. Research analysts expect that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.